Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization.
暂无分享,去创建一个
Johan T den Dunnen | Martijn H Breuning | Michel P. Villerius | Marjolein Kriek | J. D. den Dunnen | G. V. van Ommen | S. White | M. Breuning | M. Kriek | Dieuwke Engelsma | B. Bakker | Gert-Jan B van Ommen | Bert Bakker | Stefan White | Margot Kalf | Qiang Liu | Michel Villerius | Dieuwke Engelsma | Ellen Vollebregt | Qiang Liu | M. Kalf | E. Vollebregt | Ellen Vollebregt
[1] L. Kunkel,et al. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction , 1990, Human Genetics.
[2] B. McGillivray,et al. Germinal mosaicism in Duchenne muscular dystrophy , 1988, Human Genetics.
[3] L. Kunkel,et al. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing , 2001, BMC Genetics.
[4] J. Mendell,et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations , 2001, Neurology.
[5] F. Baas,et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. , 2001, Human molecular genetics.
[6] R. Regan,et al. Screening for subtelomeric chromosome abnormalities in children with idiopathic mental retardation using multiprobe telomeric FISH and the new MAPH telomeric assay , 2001, European Journal of Human Genetics.
[7] Joe W. Gray,et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas , 2001, Nature Genetics.
[8] A. Bosserhoff,et al. Use of capillary electrophoresis for high throughput screening in biomedical applications. A minireview. , 2000, Combinatorial chemistry & high throughput screening.
[9] C. Sismani,et al. Measurement of locus copy number by hybridisation with amplifiable probes. , 2000, Nucleic acids research.
[10] C. Mathew,et al. High frequency of large intragenic deletions in the Fanconi anemia group A gene. , 1999, American journal of human genetics.
[11] H. Sweeney,et al. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. , 1999, The Journal of clinical investigation.
[12] P. Møller,et al. MSH2 genomic deletions are a frequent cause of HNPCC , 1998, Nature Genetics.
[13] Peter Devilee,et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients , 1997, Nature Genetics.
[14] C. Mathew,et al. Dystrophin point mutation screening using a multiplexed protein truncation test. , 1997, Genetic testing.
[15] J. Hata,et al. Identification of carriers of Duchenne/Becker muscular dystrophy by a novel method based on detection of junction fragments in the dystrophin gene. , 1996, Journal of medical genetics.
[16] J. D. den Dunnen,et al. Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD. , 1996, Journal of medical genetics.
[17] C. Mathew,et al. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. , 1996, Journal of medical genetics.
[18] E. Rappaport,et al. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies. , 1993, American journal of medical genetics.
[19] L. Middleton,et al. Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis , 1992, Neurology.
[20] C. Mathew,et al. A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. , 1991, Journal of medical genetics.
[21] L. Kunkel,et al. Dystrophin is transcribed in brain from a distant upstream promoter. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. W. Thompson,et al. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. , 1990, American journal of human genetics.
[23] C. van Broeckhoven,et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. , 1989, American journal of human genetics.
[24] L. Kunkel,et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.
[25] M. W. Thompson,et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. , 1989, American journal of human genetics.
[26] R A Gibbs,et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.
[27] U. Francke,et al. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. , 1988, American journal of human genetics.
[28] A. Monaco,et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.
[29] M. W. Thompson,et al. Genetics of Duchenne muscular dystrophy. , 1988, Annual review of genetics.
[30] K. Davies,et al. Preferential deletion of exons in Duchenne and Becker muscular dystrophies , 1987, Nature.
[31] C. Broeckhoven,et al. Germline mosaicism and Duchenne muscular dystrophy mutations , 1987, Nature.
[32] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.